β-Hydroxybutyrate inhibits inflammasome activation to attenuate Alzheimer’s disease pathology

Alzheimer ’s disease (AD) is a progressive, late-onset dementia with no effective treatment available. Recent studies suggest that AD pathology is driven by age-related changes in metabolism. Alterations in met...

Source: Journal of Neuroinflammation - September 21, 2020 Category: Neurology Authors: Daniel C. Shippy, Connor Wilhelm, Patel A. Viharkumar, Thomas J. Raife and Tyler K. Ulland Tags: Short report Source Type: research